学习如何更有效地与中国的HCP互动

Healthcare continues to transform rapidly around the world. Especially when the COVID 19 has lasted for years. HCP engagement is at an inflection point presenting a wide range of challenges and opportunities to pharma companies. Today’s digitally-savvy HCPs expect the same level of customer-centricity they experience while interacting with digital natives across other industries. We surveyed close to 1,000 HCPs across 20+ specialties and 8 countries including China to understand how their digital preferences have evolved over last 2 years.

在新冠肺炎疫情持续多年的情况下，医疗健康行业继续在世界范围内进行迅速转型。如何和HCP的互动正处于一个拐点期，给制药公司带来了广泛的挑战和机遇。如今，精通数字化沟通的HCP希望与其他行业的数字化互动参与者一样，也能体验到同样水平的以客户为中心的互动。我们调查了包括中国在内的8个国家的20多个专业领域的近1000名HCP专家，了解他们在过去两年的数字行为偏好是如何发生改变的。

Join this webinar and panel discussion to hear from experts about HCPs’ evolving digital preferences in China and what pharma marketers and reps need to do to develop effective omnichannel marketing strategies and deliver a great HCP experience.

欢迎参加本次网络研讨会和圆桌讨论，可以听取专家们关于中国HCP数字行为偏好的发展，以及医药营销人员和销售代表需要如何制定有效的全渠道营销策略，以提供更加良好的HCP交互体验。

议程表